Mortimer T Alzona

Title: Mortimer T. Alzona: Innovator in Dendritic Cell Culture

Introduction

Mortimer T. Alzona is a notable inventor based in Vernon Hills, IL (US). He has made significant contributions to the field of immunology, particularly in the production of dendritic cells for therapeutic purposes. His innovative methods have the potential to advance treatments for various diseases, including cancer and infections.

Latest Patents

Mortimer T. Alzona holds 1 patent for his invention titled "Cytokine-free culture of dendritic cells." This patent describes a method for producing human dendritic cells without the use of cytokines or with reduced cytokine levels. The process involves culturing mononuclear cells derived from blood or bone marrow in a specialized medium containing agents such as calcium ionophores and various vitamins. The culture is maintained for a period of 4-14 days, resulting in an enriched population of dendritic cells.

Career Highlights

Alzona is associated with Nexell Therapeutics Inc., where he applies his expertise in dendritic cell culture. His work focuses on developing methods that enhance the efficacy of dendritic cells in therapeutic applications. The techniques he has developed are crucial for producing antigen-specific human T-cells, which can be used in treatments for viral and bacterial infections, as well as in cancer vaccines.

Collaborations

Throughout his career, Mortimer T. Alzona has collaborated with notable colleagues, including Mona Vachula and Dennis E. Van Epps. These collaborations have contributed to the advancement of research in dendritic cell therapies and their applications in medicine.

Conclusion

Mortimer T. Alzona's innovative work in the field of dendritic cell culture represents a significant advancement in therapeutic techniques. His contributions have the potential to improve treatment options for various diseases, showcasing the importance of innovation in medical research.